Clinical Implications of HCV Resistance

[Guest guest]

Having trouble reading this email? Click here to view in your browser.

CME-Certified Module

November 2, 2011

Resistance in Hepatitis C

Join Stephane Chevaliez, PharmD, PhD; J. Pockros, MD; and Stefan Zeuzem, MD, as they review and discuss key principles of HCV resistance with currently approved direct-acting antiviral agents, case scenarios exploring clinical strategies to minimize the risk of resistance with telaprevir and boceprevir, and the resistance considerations for potential future anti-HCV agents and regimens.

Topics covered include:

Key Resistance Principles for Currently Approved Direct-Acting Antiviral Agents

Considerations for Retreatment of Previous Peginterferon/Ribavirin Null Responders and Potential Consequences of Protease Inhibitor Resistance

Recommendations on Genotype and Resistance Testing

Implications of Resistance for Future Regimens

Current Understanding of Resistance for Direct-Acting Antiviral Agents and Regimens in Development

Clinical Implications of HCV Resistance: Laying the Foundation for Optimal Treatment Today and in the Future

http://clinicaloptions.com/Hepatitis/Treatment%20Updates/HCV%20Resistance.aspx

Hepatitis Slide Library

Review hundreds of slidesets featuring the latest hepatitis

treatment data. Then download PowerPoint files for use in your own noncommercial talks. Click here to start.

Hepatitis C

FIND THE ANSWERS AT INPRACTICE.COM

Jointly sponsored and co-provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Release date: October 25, 2011Expiration date: October 24, 2012

Supported by an independent educational grant from Roche.

Topics

Fibrosis and Cirrhosis

HIV Coinfection

HBV

NASH, ALD, etc

HCV

Other Hepatitis Viruses

Hepatocellular Carcinoma

Transplantation

Resources

Live Events

Expert Viewpoints

Bookstore

Slideset Downloads

Interactive Tools

Webcasts

Podcasts

Guidelines

Conference Coverage

CME Programs

Slidesets

Cases

Live Events

Bookstore

Resources

Site Map

RSS

Contact Us

Help

Site Requirements

Terms of Use

Privacy Policy

Hepatitis Site Tour

To ensure you receive Clinical Care Options educational materials by email,

please add info@... to your contacts or address book.

Not a member yet? Click here